FAP and neoplasm: Hence, while FAP targeting CAR-T cells therapy resulted in tumor regression due to enhanced anti-tumor immunity, it also may cause failure of immunosurveillance and alterations in normal tissues, resulting in lethal toxicity anemia and cachexia [84,85,86].